SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-077656
Filing Date
2023-07-03
Accepted
2023-07-03 16:56:52
Documents
1
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2320411-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2320411-5_4seq1.xml 4 4166
  Complete submission text file 0001104659-23-077656.txt   5654
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 66 WEST 38TH STREET, APT. 19D NEW YORK NY 10018
Business Address
Kirschbaum Mark (Reporting) CIK: 0001830211 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 231065772